Data search
Results for MligTC455_14087
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_14087 | 22 | 0.46 | Mlig455_005059 | Neo: - Age: - |
SEC14L4 | Mlig455_005059 {REF} {Length: 2564} {Pfam: CRAL/TRIO domain [PF00650.22, score=80.6]} {Human: ENSG00000133488, SEC14L4, SEC14 like lipid binding 4, [Score=145, Expect=5e-40]; ENSG00000100003, SEC14L2, SEC14 like lipid binding 2, [Score=140, Expect=7e-38]; ENSG00000214491, SEC14L6, SEC14 like lipid binding 6, [Score=139, Expect=3e-37]} {Mouse: ENSMUSG00000003585, Sec14l2, SEC14-like lipid binding 2, [Score=145, Expect=1e-39]; ENSMUSG00000054986, Sec14l3, SEC14-like lipid binding 3, [Score=142, Expect=2e-38]} {Dmel: FBgn0035146, CG13893, [Score=92.8, Expect=8e-21]} {Celegans: WBGene00011962, T23G5.2, CRAL-TRIO domain-containing protein T23G5.2, [Score=104, Expect=1e-24]} {Smed: dd_Smed_v6_12821_0_1, dd_Smed_v6_12821_0_1, [Score=155, Expect=8e-44]} {RNA1509_29843} {RNA1310_31007} {RNA815_24143} |
Cumulative graph for MligTC455_14087
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | -5.151 | 1.054 | 0.99943 | 1.00000 | |
| RegionR2 | 3.924 | 1.054 | 0.65048 | 0.98524 | |
| RegionR3 | 1.496 | 1.054 | 0.90551 | 1.00000 | |
| RegionR4 | -0.64 | 1.054 | 0.80297 | 1.00000 | |
| RegionR5 | -0.431 | 1.054 | 0.99703 | 1.00000 | |
| RegionR6 | 1.317 | 1.054 | 0.89845 | 1.00000 | |
| RegionR7 | -0.467 | 1.054 | 0.99983 | 1.00000 | |
| RegionR8 | -0.047 | 1.054 | 0.99935 | 1.00000 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | 5.288 | 1.054 | 0.99971 | 1.00000 | |
| RegenerationR2 | 2.632 | 1.054 | 0.30624 | 0.74672 | |
| RegenerationR3 | 3.976 | 1.054 | 0.32392 | 0.75149 | |
| RegenerationR4 | 2.411 | 1.054 | 0.83587 | 0.99918 | |
| RegenerationR5 | 1.802 | 1.054 | 0.37081 | 0.78078 | |
| RegenerationR6 | 0.186 | 1.054 | 0.80676 | 0.98055 | |
| RegenerationBL | 0.894 | 1.054 | 0.99991 | 1.00000 | |
| RegenerationTP | 1.507 | 1.054 | 1.00000 | 1.00000 |
Genes with expression patterns similar to MligTC455_14087
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_14087 | 22 | 0.46 | Mlig455_005059 | Neo: - Age: - |
SEC14L4 | 3 | - | 1.000 | - | - | 1.000 | 1.000 | Mlig455_005059 {REF} {Length: 2564} {Pfam: CRAL/TRIO domain [PF00650.22, score=80.6]} {Human: ENSG00000133488, SEC14L4, SEC14 like lipid binding 4, [Score=145, Expect=5e-40]; ENSG00000100003, SEC14L2, SEC14 like lipid binding 2, [Score=140, Expect=7e-38]; ENSG00000214491, SEC14L6, SEC14 like lipid binding 6, [Score=139, Expect=3e-37]} {Mouse: ENSMUSG00000003585, Sec14l2, SEC14-like lipid binding 2, [Score=145, Expect=1e-39]; ENSMUSG00000054986, Sec14l3, SEC14-like lipid binding 3, [Score=142, Expect=2e-38]} {Dmel: FBgn0035146, CG13893, [Score=92.8, Expect=8e-21]} {Celegans: WBGene00011962, T23G5.2, CRAL-TRIO domain-containing protein T23G5.2, [Score=104, Expect=1e-24]} {Smed: dd_Smed_v6_12821_0_1, dd_Smed_v6_12821_0_1, [Score=155, Expect=8e-44]} {RNA1509_29843} {RNA1310_31007} {RNA815_24143} |
| 2. | MligTC455_09326 | 21 | 0.44 | Mlig455_003882 | Neo: - Age: - Region-enriched R4: 5.436/0.02066 |
1.828 | - | 0.966 | - | - | - | 0.862 | Mlig455_003882 {REF} {Length: 401} {NoTransDecoderORF} {RNA1509_52711} {RNA1310_28410} {RNA815_12271} | |
| 3. | MligTC455_20034 | 21 | 0.43 | Mlig455_062808 | Neo: - |
1.822 | - | 0.958 | - | - | - | 0.864 | Mlig455_062808 {REF} {Length: 1094} {RNA1509_40334} {RNA1310_37951} {RNA815_18858.1} | |
| 4. | MligTC455_33798 | 7 | 0.14 | Mlig455_027571 | Neo: - Age: Up-Down-Down |
1.817 | - | 0.952 | - | - | - | 0.865 | Mlig455_027571 {REF} {Length: 843} {NoTransDecoderORF} {RNA1509_22826} {RNA1310_29458} {RNA815_7849.1} | |
| 5. | MligTC455_09327 | 39 | 0.8 | Mlig455_003671, Mlig455_003716 | Neo: - Age: - Region-enriched R4: 6.316/0.00002 |
1.812 | - | 0.961 | - | - | - | 0.851 | Mlig455_003671 {REF} {Length: 599} {NoTransDecoderORF} {RNA1509_21796} {RNA1310_28410} {RNA815_12271} Mlig455_003716 {REF} {Length: 422} {NoTransDecoderORF} {RNA1509_21796} {RNA1310_28410} {RNA815_12271} |
|
| 6. | MligTC455_17838 | 67 | 1.39 | Mlig455_050853 | Neo: Irradiation Age: - Region-enriched R4: 4.276/0.00049 |
1.81 | - | 0.977 | - | - | - | 0.833 | Mlig455_050853 {REF} {Length: 2672} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=21.3]} {Smed: dd_Smed_v6_12148_0_2, dd_Smed_v6_12148_0_2, [Score=69.7, Expect=7e-14]} {RNA1509_41080} {RNA1310_18960.1} {RNA815_9486} | |
| 7. | MligTC455_40841 | 16 | 0.34 | Mlig455_003915, Mlig455_022710 | Neo: - Age: - |
1.788 | - | 0.817 | - | - | 0.971 | - | Mlig455_003915 {REF} {Length: 3963} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=150.6]} {Mouse: ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=62.0, Expect=1e-09]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=64.3, Expect=1e-10]} {Smed: dd_Smed_v6_9790_0_1, dd_Smed_v6_9790_0_1, [Score=196, Expect=2e-55]} {RNA1509_1108} {RNA1310_105330} {RNA815_1603} Mlig455_022710 {REF} {Length: 2064} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=69.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=42.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.0]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=59.7, Expect=2e-09]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=71.2, Expect=4e-13]} {Celegans: WBGene00018728, frpr-8, FMRFamide Peptide Receptor family, [Score=54.7, Expect=6e-08]} {Smed: dd_Smed_v6_14651_0_1, dd_Smed_v6_14651_0_1, [RH, Score=161, Expect=9e-46]} {RNA1509_10628} {RNA1310_9160} {RNA815_10117.1} |
|
| 8. | MligTC455_13374 | 5 | 0.11 | Mlig455_051045 | Neo: - Age: - |
1.784 | - | 0.953 | - | - | - | 0.831 | Mlig455_051045 {REF} {Length: 531} {NoTransDecoderORF} {RNA1509_36030} {RNA1310_33431.1} {RNA815_32123} | |
| 9. | MligTC455_07609 | 814 | 16.96 | Mlig455_065903, Mlig455_070028 | Neo: Germline Age: Up-Down-Down Region-specific R4: 3.357 Region-enriched R4: 2.291/0.00800 |
A1CF | 1.779 | - | 0.827 | - | - | - | 0.952 | Mlig455_065903 {REF} {Length: 4282} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=127.1]; RNA recognition motif [PF16367.7, score=20.9]} {Human: ENSG00000148584, A1CF, APOBEC1 complementation factor, [RH, Score=444, Expect=8e-146]} {Mouse: ENSMUSG00000052595, A1cf, APOBEC1 complementation factor, [RH, Score=432, Expect=3e-141]; ENSMUSG00000070780, Rbm47, RNA binding motif protein 47, [RH, Score=421, Expect=6e-138]} {Dmel: FBgn0038826, Syp, Syncrip, [Score=332, Expect=4e-104]} {Celegans: WBGene00002000, hrp-2, HnRNP A1 homolog, [Score=276, Expect=5e-82]} {Smed: dd_Smed_v6_2228_0_1, dd_Smed_v6_2228_0_1, [RH, Score=445, Expect=2e-145]} {RNA1509_3951} {RNA1310_4587} {RNA815_9492.1} Mlig455_070028 {REF} {Length: 4546} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=127.1]; RNA recognition motif [PF16367.7, score=20.9]} {Human: ENSG00000148584, A1CF, APOBEC1 complementation factor, [RH, Score=444, Expect=1e-145]} {Mouse: ENSMUSG00000052595, A1cf, APOBEC1 complementation factor, [RH, Score=432, Expect=2e-141]; ENSMUSG00000070780, Rbm47, RNA binding motif protein 47, [RH, Score=421, Expect=6e-138]} {Dmel: FBgn0038826, Syp, Syncrip, [Score=332, Expect=4e-104]} {Celegans: WBGene00002000, hrp-2, HnRNP A1 homolog, [Score=276, Expect=4e-82]} {Smed: dd_Smed_v6_2228_0_1, dd_Smed_v6_2228_0_1, [RH, Score=444, Expect=2e-145]} {RNA1509_3951} {RNA1310_4587} {RNA815_9492.1} |
| 10. | MligTC455_33345 | 73 | 1.53 | Mlig455_022775 | Neo: - Age: Up-Down-Down |
ITPR2 | 1.751 | - | - | - | - | 0.964 | 0.787 | Mlig455_022775 {REF} {Length: 10477} {Pfam: RIH domain [PF01365.23, score=93.1]; RyR and IP3R Homology associated [PF08454.13, score=68.6]; Inositol 1,4,5-trisphosphate/ryanodine receptor [PF08709.13, score=68.1]; MIR domain [PF02815.21, score=57.0]} {Human: ENSG00000123104, ITPR2, inositol 1,4,5-trisphosphate receptor type 2, [Score=204, Expect=1e-51]} {Mouse: ENSMUSG00000030287, Itpr2, inositol 1,4,5-triphosphate receptor 2, [Score=206, Expect=3e-52]; ENSMUSG00000042644, Itpr3, inositol 1,4,5-triphosphate receptor 3, [Score=199, Expect=3e-50]} {Dmel: FBgn0010051, Itp-r83A, Inositol 1,4,5,-tris-phosphate receptor, [Score=157, Expect=1e-37]} {Celegans: WBGene00002173, itr-1, Inositol 1,4,5-trisphosphate receptor itr-1, [Score=146, Expect=2e-34]} {Smed: dd_Smed_v6_3814_1_1, dd_Smed_v6_3814_1_1, [RH, Score=3019, Expect=0.0]} {RNA1509_31887} {RNA1310_193.1} {RNA815_9899} |
| 11. | MligTC455_17181 | 23 | 0.48 | Mlig455_036265, Mlig455_055388 | Neo: - |
0.992 | - | - | - | - | - | 0.992 | Mlig455_036265 {REF} {Length: 1043} {Pfam: THAP domain [PF05485.14, score=43.7]} {Mouse: ENSMUSG00000039759, Thap3, THAP domain containing, apoptosis associated protein 3, [Score=46.2, Expect=6e-06]} {Dmel: FBgn0032730, CG10431, [Score=52.0, Expect=1e-07]} {RNA1509_30365} {RNA1310_20272} {RNA815_52972} Mlig455_055388 {REF} {Length: 1047} {Pfam: THAP domain [PF05485.14, score=43.7]} {Mouse: ENSMUSG00000039759, Thap3, THAP domain containing, apoptosis associated protein 3, [Score=46.2, Expect=6e-06]} {Dmel: FBgn0032730, CG10431, [Score=52.0, Expect=1e-07]} {RNA1509_30365} {RNA1310_20272} {RNA815_52972} |
|
| 12. | MligTC455_52935 | 29 | 0.61 | Mlig455_014479 | Neo: - Age: - |
PROX1 | 0.991 | - | - | - | - | 0.991 | - | Mlig455_014479 {REF} {Length: 1320} {Pfam: Homeo-prospero domain [PF05044.14, score=192.8]} {Human: ENSG00000117707, PROX1, prospero homeobox 1, [Score=163, Expect=5e-44]; ENSG00000119608, PROX2, prospero homeobox 2, [Score=159, Expect=4e-43]} {Mouse: ENSMUSG00000010175, Prox1, prospero homeobox 1, [Score=163, Expect=4e-44]; ENSMUSG00000042320, Prox2, prospero homeobox 2, [Score=162, Expect=2e-44]} {Dmel: FBgn0004595, pros, prospero, [Score=182, Expect=1e-50]} {Celegans: WBGene00000448, pros-1, Homeobox protein prospero homolog 1, [Score=178, Expect=1e-50]} {Smed: dd_Smed_v6_48508_0_1, dd_Smed_v6_48508_0_1, [Score=165, Expect=9e-50]} {RNA1310_102283} |
| 13. | MligTC455_43851 | 79 | 1.64 | Mlig455_031738 | Neo: - Age: - |
PI16 | 0.99 | - | - | - | - | 0.990 | - | Mlig455_031738 {REF} {Length: 2697} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=65.5]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=82.4, Expect=4e-16]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=83.2, Expect=2e-16]} {Dmel: FBgn0038126, CG8483, [Score=48.5, Expect=9e-06]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.0, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=139, Expect=3e-35]} {RNA1509_36211} {RNA1310_15740, RNA1509_36211} {RNA1509_36211, RNA815_1860.1} |
| 14. | MligTC455_08822 | 204 | 4.26 | Mlig455_021161, Mlig455_057860 | Neo: - Age: - |
GCH1 | 0.989 | - | - | - | - | 0.989 | - | Mlig455_021161 {REF} {Length: 2321} {Pfam: GTP cyclohydrolase I [PF01227.24, score=244.1]} {Human: ENSG00000131979, GCH1, GTP cyclohydrolase 1, [RH, Score=295, Expect=7e-99]} {Mouse: ENSMUSG00000037580, Gch1, GTP cyclohydrolase 1, [RH, Score=293, Expect=2e-98]} {Dmel: FBgn0003162, Pu, Punch, [Score=276, Expect=2e-91]} {Celegans: WBGene00000298, cat-4, GTP cyclohydrolase 1, [Score=286, Expect=4e-96]} {Smed: dd_Smed_v6_11172_0_1, dd_Smed_v6_11172_0_1, [RH, Score=293, Expect=6e-99]} {RNA1509_45607} {RNA1310_1536.1} {RNA815_18903} Mlig455_057860 {REF} {Length: 1963} {Pfam: GTP cyclohydrolase I [PF01227.24, score=244.0]} {Human: ENSG00000131979, GCH1, GTP cyclohydrolase 1, [RH, Score=294, Expect=1e-98]} {Mouse: ENSMUSG00000037580, Gch1, GTP cyclohydrolase 1, [RH, Score=293, Expect=3e-98]} {Dmel: FBgn0003162, Pu, Punch, [Score=277, Expect=9e-92]} {Celegans: WBGene00000298, cat-4, GTP cyclohydrolase 1, [Score=286, Expect=4e-96]} {Smed: dd_Smed_v6_11172_0_1, dd_Smed_v6_11172_0_1, [RH, Score=294, Expect=3e-99]} {RNA1509_45607} {RNA1310_1536.1} {RNA815_18903} |
| 15. | MligTC455_51176 | 71 | 1.48 | Mlig455_024765 | Neo: - Age: - |
SAXO1 | 0.988 | - | - | - | - | 0.988 | - | Mlig455_024765 {REF} {Length: 1803} {Human: ENSG00000155875, SAXO1, stabilizer of axonemal microtubules 1, [Score=48.5, Expect=9e-06]} {Smed: dd_Smed_v6_5551_0_1, dd_Smed_v6_5551_0_1, [Score=55.5, Expect=2e-08]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
| 16. | MligTC455_26248 | 162 | 3.38 | Mlig455_052600, Mlig455_052650 | Neo: - Age: - |
0.985 | - | - | - | - | 0.985 | - | Mlig455_052600 {REF} {Length: 3376} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=155.1]} {Smed: dd_Smed_v6_9633_0_1, dd_Smed_v6_9633_0_1, [Score=67.0, Expect=1e-11]} {RNA1509_10005} {RNA1310_10838.1} {RNA815_11723} Mlig455_052650 {REF} {Length: 3364} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=155.1]} {Smed: dd_Smed_v6_9633_0_1, dd_Smed_v6_9633_0_1, [Score=67.0, Expect=1e-11]} {RNA1509_10005} {RNA1310_10838.1} {RNA815_11723} |
|
| 17. | MligTC455_12817 | 26 | 0.54 | Mlig455_039450 | Neo: Int S/G2/M Age: - |
0.981 | - | - | - | - | - | 0.981 | Mlig455_039450 {REF} {Length: 1843} {RNA1310_54745} {RNA815_39086} | |
| 18. | MligTC455_33460 | 155 | 3.24 | Mlig455_043671, Mlig455_043782, Mlig455_052607 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.867/0.03359 |
0.981 | - | - | - | - | 0.981 | - | Mlig455_043671 {REF} {Length: 2416} {Pfam: SAP domain [PF02037.29, score=40.8]} {RNA1509_8096} {RNA1310_1771} {RNA815_801} Mlig455_043782 {REF} {Length: 514} {Pfam: SAP domain [PF02037.29, score=37.7]} {RNA1509_8096} {RNA1310_1771} {RNA815_801} Mlig455_052607 {REF} {Length: 497} {Pfam: SAP domain [PF02037.29, score=40.8]; SAP domain-containing new25 [PF18953.2, score=19.6]} {RNA1509_8096} {RNA1310_1771} {RNA815_801} |
|
| 19. | MligTC455_19025 | 86 | 1.79 | Mlig455_037631 | Neo: Int S/G2/M Age: Up-Down-Down |
0.979 | - | - | - | - | 0.979 | - | Mlig455_037631 {REF} {Length: 2219} {RNA1509_32306} {RNA1310_31823.1} {RNA815_14423} | |
| 20. | MligTC455_51177 | 76 | 1.59 | Mlig455_058323 | Neo: - Age: Down-Up-Up |
SAXO1 | 0.979 | - | - | - | - | 0.979 | - | Mlig455_058323 {REF} {Length: 1875} {Human: ENSG00000155875, SAXO1, stabilizer of axonemal microtubules 1, [Score=48.1, Expect=1e-05]} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=60.8, Expect=5e-11]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
| 21. | MligTC455_51179 | 75 | 1.55 | Mlig455_068660 | Neo: - Age: - |
WEE2 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_068660 {REF} {Length: 3046} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=86.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=55.7]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.4]} {Human: ENSG00000263042, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]; ENSG00000214102, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]} {Mouse: ENSMUSG00000037159, Wee2, WEE1 homolog 2 (S. pombe), [Score=102, Expect=2e-22]} {Dmel: FBgn0040298, Myt1, [Score=82.0, Expect=6e-16]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=65.1, Expect=1e-10]} {Smed: dd_Smed_v6_17244_0_1, dd_Smed_v6_17244_0_1, [Score=73.9, Expect=1e-13]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
| 22. | MligTC455_06260 | 8 | 0.16 | Mlig455_047053 | Neo: - Age: - |
GRM3 | 0.977 | - | - | - | - | 0.977 | - | Mlig455_047053 {REF} {Length: 3518} {Pfam: Receptor family ligand binding region [PF01094.30, score=246.1]; 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=181.7]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=29.0]; Periplasmic binding protein [PF13458.8, score=22.4]} {Human: ENSG00000198822, GRM3, glutamate metabotropic receptor 3, [Score=551, Expect=0.0]; ENSG00000196277, GRM7, glutamate metabotropic receptor 7, [Score=545, Expect=4e-178]; ENSG00000179603, GRM8, glutamate metabotropic receptor 8, [Score=541, Expect=5e-177]} {Mouse: ENSMUSG00000003974, Grm3, glutamate receptor, metabotropic 3, [Score=547, Expect=9e-180]; ENSMUSG00000024211, Grm8, glutamate receptor, metabotropic 8, [Score=544, Expect=3e-178]; ENSMUSG00000056755, Grm7, glutamate receptor, metabotropic 7, [Score=541, Expect=6e-177]; ENSMUSG00000023192, Grm2, glutamate receptor, metabotropic 2, [Score=530, Expect=4e-173]; ENSMUSG00000063239, Grm4, glutamate receptor, metabotropic 4, [Score=524, Expect=2e-170]} {Dmel: FBgn0050361, mtt, mangetout, [RH, Score=849, Expect=0.0]} {Celegans: WBGene00003232, mgl-1, Probable metabotropic glutamate receptor mgl-1, [Score=521, Expect=6e-169]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [Score=493, Expect=5e-157]} {RNA1310_22509} |
| 23. | MligTC455_15836 | 36 | 0.74 | Mlig455_000292 | Neo: - Age: Up-Down-Down |
PLEKHG5 | 0.976 | - | - | - | - | 0.976 | - | Mlig455_000292 {REF} {Length: 4512} {Pfam: RhoGEF domain [PF00621.22, score=89.5]; PH domain [PF17838.3, score=20.5]; Pleckstrin homology domain [PF15405.8, score=19.2]} {Human: ENSG00000171680, PLEKHG5, pleckstrin homology and RhoGEF domain containing G5, [Score=197, Expect=6e-52]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=199, Expect=5e-53]} {Dmel: FBgn0261556, CG42674, [Score=147, Expect=6e-36]} {Celegans: WBGene00006476, rhgf-2, RHGF-2; RHo Guanine nucleotide exchange Factor, [RH, Score=147, Expect=3e-36]} {Smed: dd_Smed_v6_10072_0_1, dd_Smed_v6_10072_0_1, [RH, Score=179, Expect=8e-48]} {RNA1310_47096} {RNA815_53026} |
| 24. | MligTC455_11054 | 3 | 0.06 | Mlig455_021174 | Neo: - Age: - |
ZFP36L1 | 0.975 | - | - | - | - | - | 0.975 | Mlig455_021174 {REF} {Length: 614} {Pfam: Zinc finger C-x8-C-x5-C-x3-H type (and similar) [PF00642.26, score=58.8]; Zinc finger domain [PF18345.3, score=35.7]; RNA-binding, Nab2-type zinc finger [PF14608.8, score=29.0]; CCCH-type zinc finger [PF18044.3, score=28.1]} {Human: ENSG00000185650, ZFP36L1, ZFP36 ring finger protein like 1, [Score=67.8, Expect=2e-14]; ENSG00000152518, ZFP36L2, ZFP36 ring finger protein like 2, [Score=66.2, Expect=9e-14]} {Mouse: ENSMUSG00000059334, Zfp36l3, zinc finger protein 36, C3H type-like 3, [Score=69.7, Expect=4e-15]; ENSMUSG00000021127, Zfp36l1, zinc finger protein 36, C3H type-like 1, [Score=68.6, Expect=7e-15]} {Dmel: FBgn0011837, Tis11, Tis11 zinc finger protein, [Score=69.3, Expect=4e-15]} {Celegans: WBGene00007961, C35D6.4, [RH, Score=66.6, Expect=6e-15]} {RNA1310_91211} {RNA815_52611} |
| 25. | MligTC455_11660 | 8 | 0.17 | Mlig455_064306 | Neo: - Age: Up-Down-Down |
0.975 | - | - | - | - | 0.975 | - | Mlig455_064306 {REF} {Length: 789} {Pfam: Integrase core domain [PF00665.28, score=46.4]; Integrase zinc binding domain [PF17921.3, score=28.1]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=132, Expect=1e-35]} {RNA1509_2485} {RNA1310_391} {RNA815_131.1} | |
| 26. | MligTC455_25414 | 32 | 0.66 | Mlig455_000371 | Neo: - |
TRPM3 | 0.974 | - | - | - | - | 0.974 | - | Mlig455_000371 {REF} {Length: 4372} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=75.7]; Ankyrin repeats (many copies) [PF13637.8, score=64.1]; Ankyrin repeat [PF13606.8, score=39.6]; Ankyrin repeats (many copies) [PF13857.8, score=31.8]; Ankyrin repeat [PF00023.32, score=27.0]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=80.1, Expect=2e-14]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=79.3, Expect=3e-14]; ENSMUSG00000027365, Trpm7, transient receptor potential cation channel, subfamily M, member 7, [Score=76.6, Expect=2e-13]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=78.6, Expect=3e-14]} {Celegans: WBGene00001651, gon-2, Transient receptor potential channel, [Score=64.7, Expect=4e-10]} {Smed: dd_Smed_v6_26251_0_1, dd_Smed_v6_26251_0_1, [Score=79.3, Expect=8e-15]} {RNA1509_18305} {RNA1310_1324.1} {RNA815_16630} |
| 27. | MligTC455_41738 | 22 | 0.45 | Mlig455_049770 | Neo: - Age: - |
PCIF1 | 0.973 | - | - | - | - | 0.973 | - | Mlig455_049770 {REF} {Length: 2631} {Pfam: Phosphorylated CTD interacting factor 1 WW domain [PF12237.10, score=100.0]} {Human: ENSG00000100982, PCIF1, PDX1 C-terminal inhibiting factor 1, [Score=63.2, Expect=3e-10]} {Mouse: ENSMUSG00000039849, Pcif1, PDX1 C-terminal inhibiting factor 1, [Score=62.4, Expect=4e-10]} {Smed: dd_Smed_v6_4647_0_1, dd_Smed_v6_4647_0_1, [Score=162, Expect=8e-46]} {RNA1310_17554.1} {RNA815_8653} |
| 28. | MligTC455_17468 | 54 | 1.13 | Mlig455_013421 | Neo: - Age: - Region-enriched R2: 9.270/0.00000 |
LUZP4 | 0.972 | - | - | - | - | 0.972 | - | Mlig455_013421 {REF} {Length: 1578} {Human: ENSG00000102021, LUZP4, leucine zipper protein 4, [RH, Score=62.8, Expect=5e-11]} {RNA1310_64423.1} {RNA815_29788} |
| 29. | MligTC455_40341 | 106 | 2.2 | Mlig455_060207, Mlig455_070456 | Neo: - Age: Down-Down-Up Region-enriched R2: 6.703/0.00648 |
NPY2R | 0.972 | - | - | - | - | 0.972 | - | Mlig455_060207 {REF} {Length: 3062} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=177.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=47.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=29.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.6]} {Human: ENSG00000185149, NPY2R, neuropeptide Y receptor Y2, [RH, Score=178, Expect=9e-51]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [RH, Score=176, Expect=3e-50]; ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=176, Expect=1e-49]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [Score=245, Expect=4e-74]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=215, Expect=5e-65]} {Smed: dd_Smed_v6_15335_0_1, dd_Smed_v6_15335_0_1, [RH, Score=313, Expect=2e-103]} {RNA1310_18147.1} {RNA815_7986} Mlig455_070456 {REF} {Length: 3569} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=176.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=29.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.3]} {Human: ENSG00000185149, NPY2R, neuropeptide Y receptor Y2, [RH, Score=177, Expect=8e-50]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [RH, Score=175, Expect=3e-49]; ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=174, Expect=2e-48]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [RH, Score=166, Expect=2e-44]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=215, Expect=4e-64]} {Smed: dd_Smed_v6_15335_0_1, dd_Smed_v6_15335_0_1, [RH, Score=315, Expect=8e-103]} {RNA1310_18147.1} {RNA815_7986} |
| 30. | MligTC455_11460 | 16 | 0.32 | Mlig455_007663, Mlig455_020976 | Neo: - Age: - |
GABBR2 | 0.971 | - | - | - | - | 0.971 | - | Mlig455_007663 {REF} {Length: 3796} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.8]; Receptor family ligand binding region [PF01094.30, score=95.6]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=192, Expect=5e-51]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=192, Expect=4e-51]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=184, Expect=2e-48]} {Celegans: WBGene00022675, gbb-2, GABA B receptor subunit; GABAB2 receptor subunit, [Score=186, Expect=1e-49]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=135, Expect=1e-35]} {RNA1509_46835} {RNA1310_28203} {RNA815_41974} Mlig455_020976 {REF} {Length: 3353} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=154.3]; Receptor family ligand binding region [PF01094.30, score=128.3]; Periplasmic binding protein [PF13458.8, score=20.5]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=256, Expect=8e-73]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=250, Expect=7e-71]} {Dmel: FBgn0027575, GABA-B-R2, metabotropic GABA-B receptor subtype 2, [Score=230, Expect=2e-63]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=203, Expect=3e-55]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=133, Expect=7e-35]} {RNA1310_28203} {RNA815_36847} |
| 31. | MligTC455_29262 | 96 | 2 | Mlig455_038249 | Neo: - |
0.971 | - | - | - | - | 0.971 | - | Mlig455_038249 {REF} {Length: 8932} {RNA1509_25125, RNA1509_25587, RNA1509_9188} {RNA1310_234.1, RNA1509_25125, RNA1509_25587} {RNA1509_25125, RNA1509_25587, RNA815_23.1} | |
| 32. | MligTC455_33611 | 478 | 9.95 | Mlig455_034367 | Neo: - Age: Up-Up-Up, logFC(26M/2M)=1.080 Region-enriched R4: 2.761/0.00774 |
ASAH2 | 0.969 | - | - | - | - | - | 0.969 | Mlig455_034367 {REF} {Length: 2561} {Pfam: Neutral/alkaline non-lysosomal ceramidase, N-terminal [PF04734.15, score=706.1]; Neutral/alkaline non-lysosomal ceramidase, C-terminal [PF17048.7, score=154.5]} {Human: ENSG00000188611, ASAH2, N-acylsphingosine amidohydrolase 2, [RH, Score=627, Expect=0.0]} {Mouse: ENSMUSG00000024887, Asah2, N-acylsphingosine amidohydrolase 2, [RH, Score=614, Expect=0.0]} {Dmel: FBgn0039774, CDase, Ceramidase, [RH, Score=597, Expect=0.0]} {Smed: dd_Smed_v6_1726_0_1, dd_Smed_v6_1726_0_1, [RH, Score=662, Expect=0.0]} {RNA1509_4146} {RNA1310_8395.1} {RNA815_2759} |
| 33. | MligTC455_43376 | 514 | 10.7 | Mlig455_003642 | Neo: - |
COL24A1 | 0.969 | - | - | - | - | 0.969 | - | Mlig455_003642 {REF} {Length: 4631} {Pfam: Collagen triple helix repeat (20 copies) [PF01391.20, score=485.0]; Fibrillar collagen C-terminal domain [PF01410.20, score=111.7]} {Human: ENSG00000171502, COL24A1, collagen type XXIV alpha 1 chain, [Score=370, Expect=1e-105]} {Mouse: ENSMUSG00000029661, Col1a2, collagen, type I, alpha 2, [Score=394, Expect=2e-115]} {Dmel: FBgn0000299, Col4a1, Collagen type IV alpha 1, [Score=346, Expect=1e-97]} {Celegans: WBGene00001263, emb-9, Collagen alpha-1(IV) chain, [Score=276, Expect=2e-75]} {Smed: dd_Smed_v6_8075_0_1, dd_Smed_v6_8075_0_1, [Score=473, Expect=1e-142]} {RNA1509_4709} {RNA1310_1394} {RNA815_513} |
| 34. | MligTC455_00799 | 5 | 0.1 | Mlig455_009712 | Neo: - Age: - |
0.968 | - | - | - | - | 0.968 | - | Mlig455_009712 {REF} {Length: 594} {NoTransDecoderORF} {RNA815_17525} | |
| 35. | MligTC455_14352 | 18 | 0.38 | Mlig455_057678 | Neo: - Age: - |
0.968 | - | - | - | - | 0.968 | - | Mlig455_057678 {REF} {Length: 2474} {NoTransDecoderORF} {RNA1509_25000} {RNA1310_23305} {RNA815_2326} | |
| 36. | MligTC455_36179 | 838 | 17.46 | Mlig455_012503 | Neo: - |
PLB1 | 0.968 | - | - | - | - | - | 0.968 | Mlig455_012503 {REF} {Length: 2217} {Pfam: GDSL-like Lipase/Acylhydrolase [PF00657.24, score=76.8]; GDSL-like Lipase/Acylhydrolase family [PF13472.8, score=39.4]} {Human: ENSG00000163803, PLB1, phospholipase B1, [RH, Score=294, Expect=2e-88]} {Mouse: ENSMUSG00000029134, Plb1, phospholipase B1, [RH, Score=309, Expect=8e-94]} {Dmel: FBgn0036939, CG7365, [Score=239, Expect=1e-74]} {Celegans: WBGene00022256, Y73B6BL.37, [RH, Score=245, Expect=1e-77]} {Smed: dd_Smed_v6_2690_0_1, dd_Smed_v6_2690_0_1, [Score=232, Expect=3e-72]} {RNA1509_30374, RNA1509_35882, RNA1509_40981} {RNA1310_16463, RNA1509_30374, RNA1509_35882, RNA1509_40981} {RNA1509_30374, RNA1509_35882, RNA1509_40981, RNA815_8760} |
| 37. | MligTC455_24782 | 16 | 0.33 | Mlig455_071168 | Neo: - Age: logFC(26M/2M)=-0.351 |
TTLL3 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_071168 {REF} {Length: 3703} {TRANSSPLICED} {Pfam: Tubulin-tyrosine ligase family [PF03133.17, score=244.7]; YheC/D like ATP-grasp [PF14398.8, score=21.6]} {Human: ENSG00000214021, TTLL3, tubulin tyrosine ligase like 3, [RH, Score=467, Expect=1e-152]; ENSG00000138892, TTLL8, tubulin tyrosine ligase like 8, [RH, Score=453, Expect=2e-144]} {Mouse: ENSMUSG00000030276, Ttll3, tubulin tyrosine ligase-like family, member 3, [RH, Score=507, Expect=3e-164]} {Dmel: FBgn0031854, TTLL3A, Tubulin tyrosine ligase-like 3A, [Score=363, Expect=1e-109]} {Celegans: WBGene00044187, ttll-9, Tubulin Tyrosine Ligase Like, [Score=114, Expect=8e-27]} {Smed: dd_Smed_v6_10244_0_1, dd_Smed_v6_10244_0_1, [RH, Score=612, Expect=0.0]} {RNA1509_24586, RNA1509_8170} {RNA1310_3446.1, RNA1509_24586} {RNA1509_24586, RNA815_867} |
| 38. | MligTC455_47481 | 208 | 4.33 | Mlig455_066050 | Neo: - Age: - Region-enriched R2: 3.601/0.00192 |
0.966 | - | - | - | - | 0.966 | - | Mlig455_066050 {REF} {Length: 1418} {RNA1310_25309} {RNA815_22558.1} | |
| 39. | MligTC455_50837 | 14 | 0.29 | Mlig455_013450 | Neo: - Age: - |
PLSCR5 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_013450 {REF} {Length: 1455} {Pfam: Scramblase [PF03803.17, score=121.2]} {Human: ENSG00000231213, PLSCR5, phospholipid scramblase family member 5, [Score=102, Expect=2e-24]; ENSG00000188313, PLSCR1, phospholipid scramblase 1, [Score=97.8, Expect=3e-22]} {Mouse: ENSMUSG00000095654, Plscr5, phospholipid scramblase family, member 5, [Score=102, Expect=1e-24]; ENSMUSG00000032369, Plscr1, phospholipid scramblase 1, [Score=97.8, Expect=2e-22]} {Dmel: FBgn0035390, scramb2, scramblase 2, [Score=87.8, Expect=2e-19]} {Celegans: WBGene00014200, scrm-2, Phospholipid scramblase, [Score=102, Expect=9e-25]} {Smed: dd_Smed_v6_4312_0_2, dd_Smed_v6_4312_0_2, [Score=92.4, Expect=1e-21]} {RNA1310_119369} |
| 40. | MligTC455_56085 | 3 | 0.06 | Mlig455_011162 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_011162 {REF} {Length: 371} {NoTransDecoderORF} | |
| 41. | MligTC455_13734 | 19 | 0.4 | Mlig455_066088 | Neo: - Age: Down-Up-Down |
0.965 | - | - | - | - | 0.965 | - | Mlig455_066088 {REF} {Length: 1207} {RNA1310_47485} {RNA815_44269} | |
| 42. | MligTC455_15087 | 28 | 0.59 | Mlig455_036738 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_036738 {REF} {Length: 821} {RNA1509_18025} {RNA1310_92583} {RNA815_44681} | |
| 43. | MligTC455_16559 | 61 | 1.26 | Mlig455_050729 | Neo: - Age: - Region-enriched R3: 4.650/0.00893 |
C9orf116 | 0.965 | - | - | - | - | - | 0.965 | Mlig455_050729 {REF} {Length: 952} {TRANSSPLICED} {Pfam: Domain of unknown function (DUF4490) [PF14892.8, score=113.1]} {Human: ENSG00000160345, C9orf116, chromosome 9 open reading frame 116, [RH, Score=81.3, Expect=2e-20]} {Mouse: ENSMUSG00000026831, 1700007K13Rik, RIKEN cDNA 1700007K13 gene, [RH, Score=82.4, Expect=8e-21]} {Dmel: FBgn0083943, CG34107, [RH, Score=64.7, Expect=2e-14]} {Smed: dd_Smed_v6_49903_0_1, dd_Smed_v6_49903_0_1, [RH, Score=73.2, Expect=4e-17]} {RNA1509_36646} {RNA1310_50869, RNA1509_36646} {RNA1509_36646, RNA815_31506} |
| 44. | MligTC455_16622 | 10 | 0.21 | Mlig455_057188 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_057188 {REF} {Length: 2124} {RNA1310_87812} | |
| 45. | MligTC455_18098 | 41 | 0.86 | Mlig455_009640, Mlig455_037065, Mlig455_037077 | Neo: - Age: Down-Up-Down |
TLL2 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_009640 {REF} {Length: 3563} {Pfam: CUB domain [PF00431.22, score=159.2]} {Human: ENSG00000095587, TLL2, tolloid like 2, [Score=95.5, Expect=2e-19]; ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=93.6, Expect=8e-19]} {Mouse: ENSMUSG00000025013, Tll2, tolloid-like 2, [Score=99.8, Expect=8e-21]} {Dmel: FBgn0261262, CG42613, [RH, Score=301, Expect=2e-86]} {Celegans: WBGene00002977, lev-10, LEV-10B, [RH, Score=249, Expect=5e-70]} {Smed: dd_Smed_v6_11447_0_1, dd_Smed_v6_11447_0_1, [Score=456, Expect=2e-144]} {RNA1509_40917} {RNA1310_5203.2} {RNA815_10358} Mlig455_037065 {REF} {Length: 3588} {Pfam: CUB domain [PF00431.22, score=159.1]} {Human: ENSG00000095587, TLL2, tolloid like 2, [Score=95.5, Expect=3e-19]; ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=94.4, Expect=6e-19]} {Mouse: ENSMUSG00000025013, Tll2, tolloid-like 2, [Score=99.4, Expect=1e-20]} {Dmel: FBgn0261262, CG42613, [RH, Score=300, Expect=6e-86]} {Celegans: WBGene00002977, lev-10, LEV-10B, [RH, Score=252, Expect=2e-70]} {Smed: dd_Smed_v6_11447_0_1, dd_Smed_v6_11447_0_1, [Score=461, Expect=2e-146]} {RNA1509_40917} {RNA1310_5203.2} {RNA815_10358} Mlig455_037077 {REF} {Length: 2905} {Pfam: CUB domain [PF00431.22, score=159.3]} {Human: ENSG00000095587, TLL2, tolloid like 2, [Score=95.9, Expect=2e-19]; ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=94.0, Expect=7e-19]} {Mouse: ENSMUSG00000025013, Tll2, tolloid-like 2, [Score=100, Expect=6e-21]} {Dmel: FBgn0261262, CG42613, [RH, Score=302, Expect=1e-86]} {Celegans: WBGene00002977, lev-10, LEV-10B, [RH, Score=249, Expect=2e-69]} {Smed: dd_Smed_v6_11447_0_1, dd_Smed_v6_11447_0_1, [Score=457, Expect=3e-145]} {RNA1509_40917} {RNA1310_5203.2} {RNA815_10358} |
| 46. | MligTC455_38699 | 267 | 5.56 | Mlig455_054929 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.183/0.01222 |
COLEC10 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_054929 {REF} {Length: 1403} {Pfam: Lectin C-type domain [PF00059.23, score=45.4]} {Human: ENSG00000184374, COLEC10, collectin subfamily member 10, [Score=50.4, Expect=2e-07]} {Mouse: ENSMUSG00000038591, Colec10, collectin sub-family member 10, [Score=47.8, Expect=1e-06]} {RNA1509_22697} {RNA1310_23822} {RNA815_11460} |
| 47. | MligTC455_48595 | 503 | 10.48 | Mlig455_017699 | Neo: - Age: - Region-enriched R6: 1.813/0.03812 Regeneration-downregulated R6: -2.325 Regeneration-depleted R6: -2.325 |
0.964 | - | - | - | - | 0.964 | - | Mlig455_017699 {REF} {Length: 1875} {NoTransDecoderORF} {RNA1509_38710} {RNA1310_37566} {RNA815_20664} | |
| 48. | MligTC455_19449 | 235 | 4.9 | Mlig455_048896 | Neo: - Age: logFC(26M/2M)=-0.470 Region-enriched R2: 3.185/0.00006 |
0.963 | - | - | - | - | 0.963 | - | Mlig455_048896 {REF} {Length: 1819} {Pfam: Innexin [PF00876.20, score=25.6]} {RNA1509_47060} {RNA1310_19756.1, RNA1509_47060} {RNA1509_47060, RNA815_16217} | |
| 49. | MligTC455_29874 | 65 | 1.36 | Mlig455_037947, Mlig455_068699 | Neo: - Age: logFC(26M/2M)=-0.467 |
ANKRD50 | 0.963 | - | - | - | - | 0.963 | - | Mlig455_037947 {REF} {Length: 4099} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=309.9]; Ankyrin repeat [PF00023.32, score=295.0]; Ankyrin repeat [PF13606.8, score=230.6]; Ankyrin repeats (many copies) [PF13637.8, score=228.6]; Ankyrin repeats (many copies) [PF13857.8, score=200.7]; Glutamine amidotransferase domain [PF13537.8, score=68.9]; PEGA domain [PF08308.13, score=35.0]; Mab-21 protein [PF03281.16, score=29.5]; Nucleoplasmin/nucleophosmin domain [PF03066.17, score=26.4]} {Human: ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=276, Expect=2e-75]; ENSG00000029534, ANK1, ankyrin 1, [Score=270, Expect=5e-73]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=274, Expect=8e-75]} {Dmel: FBgn0261788, Ank2, Ankyrin 2, [Score=256, Expect=7e-69]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=258, Expect=1e-69]} {Smed: dd_Smed_v6_2072_0_29, dd_Smed_v6_2072_0_29, [Score=256, Expect=2e-71]} {RNA1509_26004, RNA1509_28959} {RNA1310_3906.1, RNA1509_28959} {RNA1509_28959, RNA815_1664.1} Mlig455_068699 {REF} {Length: 2234} {Pfam: Mab-21 protein [PF03281.16, score=31.1]} {RNA1509_26004} {RNA1310_3906.1} {RNA815_1664.1} |
| 50. | MligTC455_40818 | 639 | 13.3 | Mlig455_052157, Mlig455_054166, Mlig455_060705 | Neo: - Age: - Region-enriched R2: 3.411/0.00218 Regeneration-downregulated BL: -7.120 Regeneration-depleted BL: -7.120 |
0.963 | - | - | - | - | 0.963 | - | Mlig455_052157 {REF} {Length: 1229} {RNA1310_27543} {RNA815_14190} Mlig455_054166 {REF} {Length: 1295} {RNA1310_27543} {RNA815_14190} Mlig455_060705 {REF} {Length: 1292} {RNA1310_27543} {RNA815_14190} |
|
| 51. | MligTC455_10024 | 48 | 0.99 | Mlig455_065062 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_065062 {REF} {Length: 3160} {RNA1310_7348} {RNA815_14995} | |
| 52. | MligTC455_15694 | 54 | 1.13 | Mlig455_026426, Mlig455_026456 | Neo: - Age: - Region-enriched R2: 6.151/0.00957 |
SSTR1 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_026426 {REF} {Length: 2191} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.7]; Olfactory receptor [PF13853.8, score=26.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.2]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=138, Expect=3e-36]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=140, Expect=6e-37]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=135, Expect=4e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=124, Expect=5e-31]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [Score=111, Expect=1e-26]} {Smed: dd_Smed_v6_16055_0_1, dd_Smed_v6_16055_0_1, [Score=128, Expect=2e-33]} {RNA1310_38996} {RNA815_25059} Mlig455_026456 {REF} {Length: 2423} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=134.5]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=26.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=21.3]} {Human: ENSG00000139874, SSTR1, somatostatin receptor 1, [Score=138, Expect=3e-36]} {Mouse: ENSMUSG00000035431, Sstr1, somatostatin receptor 1, [Score=140, Expect=5e-37]; ENSMUSG00000037014, Sstr4, somatostatin receptor 4, [Score=135, Expect=3e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=124, Expect=7e-31]} {Celegans: WBGene00013782, npr-32, NeuroPeptide Receptor family, [Score=110, Expect=2e-26]} {Smed: dd_Smed_v6_16055_0_1, dd_Smed_v6_16055_0_1, [Score=128, Expect=1e-33]} {RNA1310_38996} {RNA815_25059} |
| 53. | MligTC455_19097 | 120 | 2.49 | Mlig455_035179 | Neo: - Age: - Region-enriched R2: 5.873/0.00339 |
KCNK3 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_035179 {REF} {Length: 2899} {Pfam: Ion channel [PF07885.18, score=103.1]; Ion transport protein [PF00520.33, score=23.8]} {Human: ENSG00000171303, KCNK3, potassium two pore domain channel subfamily K member 3, [Score=67.0, Expect=5e-11]; ENSG00000169427, KCNK9, potassium two pore domain channel subfamily K member 9, [Score=65.9, Expect=1e-10]} {Mouse: ENSMUSG00000040901, Kcnk18, potassium channel, subfamily K, member 18, [Score=72.4, Expect=6e-13]} {Dmel: FBgn0033257, sand, sandman, [Score=105, Expect=4e-24]} {Celegans: WBGene00006690, twk-39, TWiK family of potassium channels, [RH, Score=117, Expect=4e-27]} {Smed: dd_Smed_v6_21895_0_1, dd_Smed_v6_21895_0_1, [RH, Score=188, Expect=7e-51]} {RNA1310_31604} {RNA815_54785} |
| 54. | MligTC455_25197 | 36 | 0.74 | Mlig455_059562 | Neo: - Age: - |
KY | 0.962 | - | - | - | - | 0.962 | - | Mlig455_059562 {REF} {Length: 5559} {Human: ENSG00000174611, KY, kyphoscoliosis peptidase, [Score=77.0, Expect=2e-13]} {Mouse: ENSMUSG00000035606, Ky, kyphoscoliosis peptidase, [Score=79.0, Expect=2e-14]} {Dmel: FBgn0050147, Hil, Hillarin, [Score=78.6, Expect=3e-14]} {Celegans: WBGene00003089, ltd-1, Lim and Transglutaminase Domain; Lim and transglutaminase domain protein, [Score=68.2, Expect=3e-11]} {Smed: dd_Smed_v6_1109_0_1, dd_Smed_v6_1109_0_1, [Score=100, Expect=5e-21]} {RNA1509_6021} {RNA1310_875.1} {RNA815_349} |
| 55. | MligTC455_36520 | 30 | 0.63 | Mlig455_018928 | Neo: - Age: - |
0.962 | - | - | - | - | - | 0.962 | Mlig455_018928 {REF} {Length: 960} {RNA1509_13252, RNA1509_31672} {RNA1310_38041, RNA1509_31672} {RNA1509_31672, RNA815_26976} | |
| 56. | MligTC455_37026 | 109 | 2.28 | Mlig455_029463 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_029463 {REF} {Length: 788} {RNA1310_43520} {RNA815_2407} | |
| 57. | MligTC455_46188 | 25 | 0.51 | Mlig455_039664, Mlig455_039727 | Neo: - Age: - |
0.962 | - | - | - | - | 0.962 | - | Mlig455_039664 {REF} {Length: 1353} Mlig455_039727 {REF} {Length: 1348} |
|
| 58. | MligTC455_46723 | 138 | 2.87 | Mlig455_066171 | Neo: - Age: - |
CHRNA6 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_066171 {REF} {Length: 1617} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=107.0]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=48.7]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=127, Expect=8e-32]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=123, Expect=2e-30]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=122, Expect=6e-30]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=131, Expect=2e-33]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=130, Expect=2e-33]} {Celegans: WBGene00006765, unc-29, Acetylcholine receptor subunit beta-type unc-29, [Score=92.0, Expect=4e-20]} {Smed: dd_Smed_v6_14630_0_1, dd_Smed_v6_14630_0_1, [Score=142, Expect=2e-37]} {RNA1509_55012} {RNA1310_6313.1} {RNA815_3014.1} |
| 59. | MligTC455_48320 | 81 | 1.69 | Mlig455_008829 | Neo: - Age: Down-Down-Up |
TOB1 | 0.962 | - | - | - | - | 0.962 | - | Mlig455_008829 {REF} {Length: 832} {Pfam: BTG family [PF07742.14, score=62.3]} {Human: ENSG00000141232, TOB1, transducer of ERBB2, 1, [Score=64.7, Expect=2e-12]} {Mouse: ENSMUSG00000037573, Tob1, transducer of ErbB-2.1, [Score=63.2, Expect=4e-12]} {Dmel: FBgn0028397, Tob, [Score=68.6, Expect=5e-14]} {Smed: dd_Smed_v6_7444_0_1, dd_Smed_v6_7444_0_1, [Score=75.1, Expect=5e-17]} {RNA1509_42403, RNA1509_59615} {RNA1310_49803, RNA1509_42403, RNA1509_59615} |
| 60. | MligTC455_14975 | 173 | 3.61 | Mlig455_050558, Mlig455_050588 | Neo: - Age: - |
0.96 | - | - | - | - | - | 0.960 | Mlig455_050558 {REF} {Length: 1652} {RNA1310_120172} Mlig455_050588 {REF} {Length: 1652} {NoTransDecoderORF} {RNA1310_120172} |
|
| 61. | MligTC455_13065 | 148 | 3.08 | Mlig455_043686, Mlig455_043753, Mlig455_047472 | Neo: - Age: - |
RGS12, RGS3 | 0.959 | - | - | - | - | 0.959 | - | Mlig455_043686 {REF} {Length: 3598} {Pfam: PDZ domain [PF00595.26, score=38.7]; C2 domain [PF00168.32, score=38.5]; PDZ domain [PF17820.3, score=36.6]; PDZ domain [PF13180.8, score=23.2]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=86.3, Expect=4e-17]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=85.1, Expect=6e-17]} {Dmel: FBgn0020278, loco, locomotion defects, [Score=62.8, Expect=7e-10]} {Smed: dd_Smed_v6_17732_0_1, dd_Smed_v6_17732_0_1, [RH, Score=105, Expect=9e-24]} {RNA1310_17293.2} Mlig455_043753 {REF} {Length: 1508} {Pfam: PDZ domain [PF00595.26, score=39.7]; PDZ domain [PF17820.3, score=37.4]; PDZ domain [PF13180.8, score=24.1]} {Human: ENSG00000159788, RGS12, regulator of G protein signaling 12, [Score=64.3, Expect=1e-10]} {Mouse: ENSMUSG00000029101, Rgs12, regulator of G-protein signaling 12, [Score=64.7, Expect=7e-11]} {Dmel: FBgn0020278, loco, locomotion defects, [Score=62.0, Expect=4e-10]} {Smed: dd_Smed_v6_17732_0_1, dd_Smed_v6_17732_0_1, [Score=73.9, Expect=3e-14]} {RNA1310_80665} Mlig455_047472 {REF} {Length: 2285} {TRANSSPLICED} {Pfam: C2 domain [PF00168.32, score=38.8]; PDZ domain [PF00595.26, score=38.8]; PDZ domain [PF17820.3, score=36.6]; PDZ domain [PF13180.8, score=23.2]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=84.7, Expect=1e-16]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=85.5, Expect=4e-17]} {Dmel: FBgn0020278, loco, locomotion defects, [Score=62.4, Expect=9e-10]} {Smed: dd_Smed_v6_17732_0_1, dd_Smed_v6_17732_0_1, [RH, Score=103, Expect=5e-23]} {RNA1310_17293.2} |
| 62. | MligTC455_08640 | 174 | 3.62 | Mlig455_002177 | Neo: Irradiation Age: - Region-specific R4: 4.604 |
0.958 | - | - | - | - | - | 0.958 | Mlig455_002177 {REF} {Length: 984} {RNA1509_28941} {RNA1310_12423} {RNA815_39974} | |
| 63. | MligTC455_12942 | 16 | 0.33 | Mlig455_033008 | Neo: - Age: - |
CHRNA10 | 0.958 | - | - | - | - | 0.958 | - | Mlig455_033008 {REF} {Length: 2331} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=183.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=55.8]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=189, Expect=7e-55]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=186, Expect=1e-53]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=185, Expect=5e-53]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=181, Expect=5e-51]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=181, Expect=5e-51]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=196, Expect=1e-57]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=180, Expect=3e-51]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=184, Expect=5e-53]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=214, Expect=7e-64]} {RNA1509_38665} {RNA1310_30702} {RNA815_28553} |
| 64. | MligTC455_50328 | 128 | 2.66 | Mlig455_039843 | Neo: - Age: - |
SCNN1B | 0.958 | - | - | - | - | 0.958 | - | Mlig455_039843 {REF} {Length: 2793} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=206.6]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=69.3, Expect=1e-11]} {Mouse: ENSMUSG00000000216, Scnn1g, sodium channel, nonvoltage-gated 1 gamma, [Score=58.9, Expect=1e-08]; ENSMUSG00000030873, Scnn1b, sodium channel, nonvoltage-gated 1 beta, [Score=57.4, Expect=4e-08]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=75.5, Expect=8e-14]} {Smed: dd_Smed_v6_23028_0_1, dd_Smed_v6_23028_0_1, [RH, Score=366, Expect=3e-118]} {RNA1509_37054} {RNA1310_10450, RNA1509_37054} {RNA1509_37054, RNA815_17111} |
| 65. | MligTC455_13030 | 30 | 0.63 | Mlig455_030520 | Neo: - Age: - |
0.957 | - | - | - | - | 0.957 | - | Mlig455_030520 {REF} {Length: 3950} {RNA1509_41925} {RNA1310_32300.1, RNA1509_41925} {RNA1509_41925, RNA815_29217} | |
| 66. | MligTC455_38813 | 50 | 1.04 | Mlig455_008881 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.104/0.01060 |
THSD7A | 0.957 | - | - | - | - | 0.957 | - | Mlig455_008881 {REF} {Length: 6770} {Pfam: Spondin-like TSP1 domain [PF19028.2, score=138.6]; Thrombospondin type 1 domain [PF19030.2, score=34.2]; Thrombospondin type 1 domain [PF00090.21, score=26.3]} {Human: ENSG00000005108, THSD7A, thrombospondin type 1 domain containing 7A, [Score=298, Expect=5e-81]} {Mouse: ENSMUSG00000032625, Thsd7a, thrombospondin, type I, domain containing 7A, [Score=303, Expect=8e-83]} {Celegans: WBGene00001650, gon-1, A disintegrin and metalloproteinase with thrombospondin motifs gon-1, [Score=54.7, Expect=8e-07]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=50.4, Expect=1e-05]} {RNA1310_90350} |
| 67. | MligTC455_49907 | 79 | 1.65 | Mlig455_059454 | Neo: - Age: Up-Down-Down |
0.957 | - | - | - | - | 0.957 | - | Mlig455_059454 {REF} {Length: 2213} {Pfam: Otopetrin [PF03189.15, score=92.9]} {Dmel: FBgn0259994, CG42492, [Score=79.3, Expect=3e-16]} {Celegans: WBGene00018478, otpl-5, OToPetrin-Like, [Score=75.5, Expect=3e-15]} {Smed: dd_Smed_v6_15458_0_1, dd_Smed_v6_15458_0_1, [Score=90.1, Expect=4e-20]} {RNA1310_31431.1} {RNA815_29709} | |
| 68. | MligTC455_15333 | 618 | 12.86 | Mlig455_004406, Mlig455_037227 | Neo: - Age: - |
PDZRN3, TRIM65 | 0.956 | - | - | - | - | - | 0.956 | Mlig455_004406 {REF} {Length: 2142} {Pfam: Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=34.7]; RING-type zinc-finger [PF13445.8, score=28.1]; Ring finger domain [PF13639.8, score=27.6]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=25.2]; zinc finger of C3HC4-type, RING [PF15227.8, score=24.9]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=23.5]; zinc-RING finger domain [PF14634.8, score=20.7]; Prokaryotic RING finger family 4 [PF14447.8, score=19.8]} {Human: ENSG00000141569, TRIM65, tripartite motif containing 65, [RH, Score=72.4, Expect=1e-13]} {Mouse: ENSMUSG00000035357, Pdzrn3, PDZ domain containing RING finger 3, [Score=58.5, Expect=6e-09]; ENSMUSG00000035235, Trim13, tripartite motif-containing 13, [Score=57.0, Expect=1e-08]; ENSMUSG00000054517, Trim65, tripartite motif-containing 65, [Score=56.6, Expect=2e-08]} {Dmel: FBgn0020224, Cbl, Cbl proto-oncogene, [Score=50.1, Expect=2e-06]} {Celegans: WBGene00004829, sli-1, Sli-1 protein; Suppressor of LIneage defect, [Score=50.1, Expect=1e-06]} {Smed: dd_Smed_v6_14782_0_2, dd_Smed_v6_14782_0_2, [Score=45.8, Expect=1e-05]} {RNA1509_55221} {RNA1310_21941.1} {RNA815_9209} Mlig455_037227 {REF} {Length: 2155} {Pfam: Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=35.2]; RING-type zinc-finger [PF13445.8, score=29.7]; Ring finger domain [PF13639.8, score=28.3]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=26.0]; zinc finger of C3HC4-type, RING [PF15227.8, score=25.3]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=23.9]; zinc-RING finger domain [PF14634.8, score=21.2]; Prokaryotic RING finger family 4 [PF14447.8, score=20.4]} {Human: ENSG00000121440, PDZRN3, PDZ domain containing ring finger 3, [Score=59.7, Expect=1e-09]} {Mouse: ENSMUSG00000035357, Pdzrn3, PDZ domain containing RING finger 3, [Score=59.7, Expect=9e-10]} {Dmel: FBgn0020224, Cbl, Cbl proto-oncogene, [Score=49.3, Expect=2e-06]} {Celegans: WBGene00004829, sli-1, Sli-1 protein; Suppressor of LIneage defect, [Score=49.3, Expect=1e-06]} {RNA1509_55221} {RNA1310_21941.1} {RNA815_9209} |
| 69. | MligTC455_52746 | 33 | 0.7 | Mlig455_036774 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_036774 {REF} {Length: 1992} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=90.0]} {Smed: dd_Smed_v6_16274_0_1, dd_Smed_v6_16274_0_1, [Score=77.4, Expect=7e-15]} {RNA1310_26715} {RNA815_32348} | |
| 70. | MligTC455_04669 | 26 | 0.54 | Mlig455_069462 | Neo: Germline Age: - Region-enriched R4: 6.196/0.00208 |
0.955 | - | - | - | - | - | 0.955 | Mlig455_069462 {REF} {Length: 738} {RNA1509_24791} {RNA1310_64927} {RNA815_45377.1} | |
| 71. | MligTC455_12438 | 17 | 0.35 | Mlig455_009594 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274} | |
| 72. | MligTC455_15996 | 396 | 8.26 | Mlig455_064976, Mlig455_066809 | Neo: - Age: - |
ARHGEF17 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_064976 {REF} {Length: 4968} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=136.4]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [Score=233, Expect=6e-61]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [Score=239, Expect=3e-63]} {Dmel: FBgn0262562, CG43102, [RH, Score=520, Expect=4e-156]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [RH, Score=240, Expect=2e-64]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=713, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_14497} Mlig455_066809 {REF} {Length: 5061} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=125.9]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [RH, Score=266, Expect=2e-71]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [RH, Score=264, Expect=1e-70]} {Dmel: FBgn0262562, CG43102, [RH, Score=503, Expect=8e-150]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [Score=224, Expect=3e-59]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=691, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_23184} |
| 73. | MligTC455_32597 | 106 | 2.2 | Mlig455_003631, Mlig455_033245 | Neo: - Age: - |
SSUH2 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_003631 {REF} {Length: 1926} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=112, Expect=3e-27]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=73.2, Expect=5e-14]} {RNA1509_32165} {RNA1310_13450} {RNA815_5462.1} Mlig455_033245 {REF} {Length: 3547} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=116, Expect=2e-28]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=75.9, Expect=9e-15]} {RNA1509_32165} {RNA1310_13450, RNA1509_32165} {RNA1509_32165, RNA815_5462.1} |
| 74. | MligTC455_41296 | 43 | 0.9 | Mlig455_021118 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_021118 {REF} {Length: 2049} {RNA1509_59262} {RNA1310_31928} {RNA815_32415} | |
| 75. | MligTC455_50079 | 25 | 0.51 | Mlig455_003362 | Neo: - Age: - |
SLC26A2 | 0.955 | - | 0.955 | - | - | - | - | Mlig455_003362 {REF} {Length: 2587} {Pfam: Sulfate permease family [PF00916.22, score=287.8]; STAS domain [PF01740.23, score=66.3]; STAS domain [PF13466.8, score=25.8]} {Human: ENSG00000155850, SLC26A2, solute carrier family 26 member 2, [Score=312, Expect=1e-95]; ENSG00000170615, SLC26A5, solute carrier family 26 member 5, [Score=307, Expect=1e-93]} {Mouse: ENSMUSG00000034320, Slc26a2, solute carrier family 26 (sulfate transporter), member 2, [Score=314, Expect=3e-96]; ENSMUSG00000029015, Slc26a5, solute carrier family 26, member 5, [Score=311, Expect=3e-95]; ENSMUSG00000040441, Slc26a10, solute carrier family 26, member 10, [Score=300, Expect=9e-92]} {Dmel: FBgn0036770, Prestin, [Score=272, Expect=1e-80]} {Celegans: WBGene00013963, sulp-8, Anion transporter SULP-8a; Anion transporter SULP-8b; SULfate Permease family, [Score=320, Expect=2e-100]} {Smed: dd_Smed_v6_16869_0_1, dd_Smed_v6_16869_0_1, [Score=397, Expect=6e-131]} {RNA1509_41170} {RNA1310_1621.1} {RNA815_14105} |
| 76. | MligTC455_21204 | 2389 | 49.77 | Mlig455_029473 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-0.413 Region-specific R4: 5.657 Region-enriched R4: 3.210/0.00000 Regeneration-downregulated R4: -2.346 Regeneration-depleted R4: -2.346 |
0.954 | - | - | - | - | - | 0.954 | Mlig455_029473 {REF} {Length: 2272} {RNA1509_1175, RNA1509_21740, RNA1509_23125, RNA1509_4067, RNA1509_46797, RNA1509_58674} {RNA1310_21425.1, RNA1509_1175, RNA1509_21740, RNA1509_23125, RNA1509_4067, RNA1509_46797, RNA1509_58674} {RNA1509_1175, RNA1509_21740, RNA1509_23125, RNA1509_4067, RNA1509_46797, RNA1509_58674, RNA815_2074} | |
| 77. | MligTC455_21638 | 50 | 1.05 | Mlig455_026393 | Neo: - Age: Down-Up-Down |
SLC6A5 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_026393 {REF} {Length: 1896} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=352.8]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=310, Expect=2e-97]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=309, Expect=3e-97]} {Dmel: FBgn0034911, CG5549, [Score=310, Expect=6e-95]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=226, Expect=2e-67]} {Smed: dd_Smed_v6_10458_0_1, dd_Smed_v6_10458_0_1, [Score=276, Expect=1e-85]} {RNA1509_16390} {RNA1310_7302.2} {RNA815_18232} |
| 78. | MligTC455_31345 | 102 | 2.12 | Mlig455_004435, Mlig455_004447 | Neo: - Age: - |
RTL1 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_004435 {REF} {Length: 551} {RNA1310_70973} {RNA815_36768} Mlig455_004447 {REF} {Length: 2743} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=93.3]; Integrase zinc binding domain [PF17921.3, score=77.6]; RNase H-like domain found in reverse transcriptase [PF17919.3, score=45.9]} {Human: ENSG00000254656, RTL1, retrotransposon Gag like 1, [Score=75.9, Expect=2e-13]} {Smed: dd_Smed_v6_3718_0_2, dd_Smed_v6_3718_0_2, [Score=255, Expect=1e-71]} {RNA1509_33330} {RNA1310_5975.2} {RNA815_11487} |
| 79. | MligTC455_34693 | 336 | 7 | Mlig455_017459 | Neo: - Age: - Region-enriched R2: 6.024/0.00000 |
FZD4 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_017459 {REF} {Length: 3882} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=335.8]; Fz domain [PF01392.24, score=90.0]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=424, Expect=3e-141]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=423, Expect=3e-141]} {Dmel: FBgn0001085, fz, frizzled, [Score=306, Expect=2e-95]} {Celegans: WBGene00003006, lin-17, Transmembrane receptor LIN-17, [RH, Score=271, Expect=1e-82]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=473, Expect=3e-160]} {RNA1509_10294} {RNA1310_2672} {RNA815_3209} |
| 80. | MligTC455_35505 | 126 | 2.62 | Mlig455_018997, Mlig455_022533, Mlig455_055707 | Neo: - Age: - |
HRH2, SYT7 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_018997 {REF} {Length: 4854} {Pfam: C2 domain [PF00168.32, score=156.5]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=271, Expect=9e-84]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=261, Expect=3e-81]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [RH, Score=243, Expect=4e-76]} {Celegans: WBGene00004926, snt-6, SyNapTotagmin, [RH, Score=182, Expect=1e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=199, Expect=6e-60]} {RNA1310_29722} {RNA815_16467} Mlig455_022533 {REF} {Length: 1223} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=80.1]} {Human: ENSG00000113749, HRH2, histamine receptor H2, [Score=68.6, Expect=4e-12]} {Mouse: ENSMUSG00000044338, Aplnr, apelin receptor, [Score=64.3, Expect=7e-11]; ENSMUSG00000037424, Taar9, trace amine-associated receptor 9, [Score=63.9, Expect=9e-11]; ENSMUSG00000034987, Hrh2, histamine receptor H2, [Score=63.2, Expect=2e-10]} {Dmel: FBgn0039595, AstA-R2, Allatostatin A receptor 2, [Score=53.1, Expect=2e-07]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [Score=63.2, Expect=9e-11]} Mlig455_055707 {REF} {Length: 2803} {Pfam: C2 domain [PF00168.32, score=156.6]} {Human: ENSG00000011347, SYT7, synaptotagmin 7, [RH, Score=270, Expect=2e-83]} {Mouse: ENSMUSG00000024743, Syt7, synaptotagmin VII, [RH, Score=259, Expect=4e-81]} {Dmel: FBgn0039900, Syt7, Synaptotagmin 7, [RH, Score=243, Expect=2e-76]} {Celegans: WBGene00004926, snt-6, SyNapTotagmin, [RH, Score=182, Expect=1e-53]} {Smed: dd_Smed_v6_4222_0_1, dd_Smed_v6_4222_0_1, [Score=199, Expect=4e-60]} {RNA1310_29722} {RNA815_16467} |
| 81. | MligTC455_04309 | 5 | 0.11 | Mlig455_037595 | Neo: - Age: - |
0.952 | - | 0.952 | - | - | - | - | Mlig455_037595 {REF} {Length: 625} {RNA1509_30182} {RNA1310_25153} {RNA815_11770} | |
| 82. | MligTC455_08533 | 3 | 0.06 | Mlig455_060531 | Neo: - Age: - |
0.952 | - | 0.952 | - | - | - | - | Mlig455_060531 {REF} {Length: 284} {NoTransDecoderORF} | |
| 83. | MligTC455_45881 | 285 | 5.94 | Mlig455_051535 | Neo: Irradiation Age: Up-Down-Down Region-enriched R2: 4.287/0.00883 |
CALM2 | 0.952 | - | - | - | - | 0.952 | - | Mlig455_051535 {REF} {Length: 1911} {Pfam: EF-hand domain pair [PF13499.8, score=44.7]; EF-hand domain [PF14658.8, score=28.5]; EF-hand domain [PF13405.8, score=18.6]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=83.2, Expect=5e-18]; ENSG00000198668, CALM1, calmodulin 1, [Score=83.2, Expect=1e-18]; ENSG00000160014, CALM3, calmodulin 3, [Score=82.8, Expect=2e-18]} {Mouse: ENSMUSG00000036438, Calm2, calmodulin 2, [Score=82.8, Expect=1e-18]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=82.8, Expect=1e-18]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=82.8, Expect=1e-18]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=82.4, Expect=1e-18]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=82.4, Expect=1e-18]} {RNA1509_41430} {RNA1310_57772} {RNA815_28870} |
| 84. | MligTC455_56541 | 6 | 0.13 | Mlig455_037485 | Neo: - Age: - |
0.952 | - | 0.952 | - | - | - | - | Mlig455_037485 {REF} {Length: 312} {NoTransDecoderORF} | |
| 85. | MligTC455_11758 | 6 | 0.12 | Mlig455_051325 | Neo: - Age: - |
ZNRF3 | 0.951 | - | 0.951 | - | - | - | - | Mlig455_051325 {REF} {Length: 2005} {Pfam: Ring finger domain [PF13639.8, score=47.1]; RING-like zinc finger [PF17123.7, score=44.3]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=34.9]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=30.0]; RING-H2 zinc finger domain [PF12678.9, score=28.8]; zinc-RING finger domain [PF14634.8, score=25.0]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=24.1]; Anaphase-promoting complex subunit 11 RING-H2 finger [PF12861.9, score=21.4]; RING-type zinc-finger [PF13445.8, score=20.9]; ZNRF-3 Ectodomain [PF18212.3, score=20.6]} {Human: ENSG00000183579, ZNRF3, zinc and ring finger 3, [Score=91.3, Expect=2e-19]} {Mouse: ENSMUSG00000041961, Znrf3, zinc and ring finger 3, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0052850, CG32850, [Score=60.8, Expect=5e-11]} {Celegans: WBGene00023404, plr-1, Probable E3 ubiquitin-protein ligase plr-1, [RH, Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_2844_0_1, dd_Smed_v6_2844_0_1, [Score=70.9, Expect=1e-13]} {RNA1509_33706} {RNA1310_73291} {RNA815_59739} |
| 86. | MligTC455_14667 | 6 | 0.12 | Mlig455_023220 | Neo: - Age: - |
PIK3CA | 0.951 | - | 0.951 | - | - | - | - | Mlig455_023220 {REF} {Length: 1002} {Human: ENSG00000121879, PIK3CA, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, [Score=113, Expect=2e-27]} {Mouse: ENSMUSG00000027665, Pik3ca, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, [Score=114, Expect=7e-28]} {Dmel: FBgn0015279, Pi3K92E, [Score=94.7, Expect=2e-21]} {Celegans: WBGene00000090, age-1, Phosphatidylinositol 3-kinase age-1, [Score=69.7, Expect=4e-13]} {Smed: dd_Smed_v6_8025_0_1, dd_Smed_v6_8025_0_1, [Score=108, Expect=3e-26]} {RNA1509_9204} {RNA1310_64803} {RNA815_1006} |
| 87. | MligTC455_37747 | 25 | 0.53 | Mlig455_024090 | Neo: - Age: - Region-enriched R4: 6.148/0.01140 |
0.951 | - | - | - | - | 0.951 | - | Mlig455_024090 {REF} {Length: 223} {NoTransDecoderORF} {RNA1509_2515} {RNA1310_11167.1} {RNA815_3258.1} | |
| 88. | MligTC455_39632 | 71 | 1.48 | Mlig455_039338 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.404/0.02299 |
APBA1 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_039338 {REF} {Length: 5781} {Pfam: Phosphotyrosine interaction domain (PTB/PID) [PF00640.25, score=122.8]; PDZ domain [PF00595.26, score=87.0]; PDZ domain [PF17820.3, score=50.7]} {Human: ENSG00000107282, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=476, Expect=5e-157]; ENSG00000276497, APBA1, amyloid beta precursor protein binding family A member 1, [RH, Score=474, Expect=2e-161]; ENSG00000276495, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]; ENSG00000034053, APBA2, amyloid beta precursor protein binding family A member 2, [RH, Score=474, Expect=3e-157]} {Mouse: ENSMUSG00000030519, Apba2, amyloid beta (A4) precursor protein-binding, family A, member 2, [RH, Score=476, Expect=3e-158]; ENSMUSG00000024897, Apba1, amyloid beta (A4) precursor protein binding, family A, member 1, [RH, Score=475, Expect=2e-156]} {Dmel: FBgn0052677, X11Lbeta, [Score=532, Expect=2e-168]} {Celegans: WBGene00002999, lin-10, [Score=519, Expect=1e-172]} {Smed: dd_Smed_v6_2836_0_2, dd_Smed_v6_2836_0_2, [Score=550, Expect=0.0]} {RNA1509_43941, RNA1509_55204} {RNA1310_18864.1, RNA1509_43941} {RNA1509_43941, RNA815_11653} |
| 89. | MligTC455_43950 | 2296 | 47.84 | Mlig455_029261, Mlig455_035647, Mlig455_035748 | Neo: - Age: - Regeneration-downregulated BL: -2.094 Regeneration-depleted BL: -2.094 |
0.951 | - | - | - | - | 0.951 | - | Mlig455_029261 {REF} {Length: 2798} {RNA1509_28538, RNA1509_39513, RNA1509_9241} {RNA1310_10383, RNA1509_28538, RNA1509_39513, RNA1509_9241} {RNA1509_28538, RNA1509_39513, RNA1509_9241, RNA815_3519} Mlig455_035647 {REF} {Length: 2505} {RNA1509_9241} {RNA1310_10383} {RNA815_3519} Mlig455_035748 {REF} {Length: 2496} {RNA1509_9241} {RNA1310_10383} {RNA815_3519} |
|
| 90. | MligTC455_45943 | 66 | 1.38 | Mlig455_012164 | Neo: - Age: Up-Up-Down |
NPR2 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_012164 {REF} {Length: 4580} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=225.3]; Receptor family ligand binding region [PF01094.30, score=169.5]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=126.7]; Protein kinase domain [PF00069.27, score=114.0]; Heme NO binding associated [PF07701.16, score=19.2]} {Human: ENSG00000159899, NPR2, natriuretic peptide receptor 2, [RH, Score=791, Expect=0.0]} {Mouse: ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [RH, Score=629, Expect=0.0]} {Dmel: FBgn0051183, CG31183, [RH, Score=826, Expect=0.0]} {Celegans: WBGene00020131, gcy-28, Receptor-type guanylate cyclase gcy-28, [RH, Score=600, Expect=0.0]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [RH, Score=955, Expect=0.0]} {RNA1509_42903} {RNA1310_5627} {RNA815_1811} |
| 91. | MligTC455_52223 | 30 | 0.62 | Mlig455_029799 | Neo: - Age: - |
GLRA2 | 0.951 | - | - | - | - | 0.951 | - | Mlig455_029799 {REF} {Length: 3197} {tRNA: Val(CAC),pseudo, score=27.6} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=152.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=122.6]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [RH, Score=350, Expect=1e-116]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [RH, Score=345, Expect=4e-115]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [RH, Score=338, Expect=3e-112]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [RH, Score=345, Expect=3e-115]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [RH, Score=342, Expect=2e-113]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [RH, Score=337, Expect=9e-112]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [RH, Score=334, Expect=1e-110]} {Dmel: FBgn0024963, GluClalpha, [RH, Score=301, Expect=8e-98]} {Celegans: WBGene00000232, avr-14, Inhibitory amino acid receptor subunit gbr-2A, [RH, Score=274, Expect=3e-88]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=265, Expect=1e-84]} {RNA1509_44790} {RNA1310_18585} {RNA815_38424} |
| 92. | MligTC455_18533 | 46 | 0.96 | Mlig455_013010 | Neo: - Age: Down-Down-Up |
LOXL3 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_013010 {REF} {Length: 2040} {Pfam: Lysyl oxidase [PF01186.19, score=256.6]; Scavenger receptor cysteine-rich domain [PF00530.20, score=103.8]; Scavenger receptor cysteine-rich domain [PF15494.8, score=30.0]} {Human: ENSG00000115318, LOXL3, lysyl oxidase like 3, [RH, Score=272, Expect=2e-83]} {Mouse: ENSMUSG00000000693, Loxl3, lysyl oxidase-like 3, [RH, Score=275, Expect=2e-83]; ENSMUSG00000034205, Loxl2, lysyl oxidase-like 2, [RH, Score=265, Expect=3e-79]} {Dmel: FBgn0034660, lox2, lysyl oxidase-like 2, [Score=308, Expect=1e-98]} {Smed: dd_Smed_v6_10591_0_1, dd_Smed_v6_10591_0_1, [Score=307, Expect=8e-99]} {RNA1509_21249} {RNA1310_15268.1, RNA1509_21249} {RNA1509_21249, RNA815_5714} |